Rapid Pregnancy Testing

Rapid Pregnancy Testing Market Outlook

The global pregnancy testing market was valued at approximately USD 3.5 billion in 2023 and is projected to grow at a CAGR of around 8.7% from 2025 to 2035. This growth can be attributed to the increasing awareness surrounding reproductive health, the rise in unplanned pregnancies, and the expanding availability of rapid pregnancy test kits in both healthcare settings and retail outlets. Moreover, innovations in technology are facilitating the development of more accurate and user-friendly pregnancy tests, enhancing consumer confidence and driving market penetration. Additionally, a rising trend toward at-home testing options is expected to further fuel the demand for rapid testing solutions, as consumers seek privacy and convenience in their healthcare decisions. It is paramount for stakeholders in this market to capitalize on these trends to bolster product offerings and reach a wider audience.

Growth Factor of the Market

Several factors are propelling the growth of the rapid pregnancy testing market. Firstly, the growing emphasis on family planning and reproductive health is making individuals more conscious of the need for timely pregnancy tests, thereby increasing demand. Secondly, technological advancements in the development of sensitive and precise detection methods are enhancing the accuracy of tests, instilling further confidence in users. Thirdly, the shift towards home testing solutions provides a significant convenience factor, allowing for privacy and ease-of-use that traditional testing methods cannot offer. Additionally, the increasing adoption of these tests in healthcare facilities, such as hospitals and clinics, aids in timely diagnoses and expands the market reach. Lastly, aggressive marketing strategies by manufacturers and the expansion of distribution channels are ensuring that these products are readily accessible to a broader demographic.

Key Highlights of the Market

• The market is anticipated to witness a robust growth rate, driven by an increase in the adoption of home testing kits.
• Technological advancements are leading to the development of more accurate and user-friendly products.
• The availability of rapid tests in diverse distribution channels is enhancing market penetration.
• Consumer awareness regarding reproductive health has significantly increased, driving demand for pregnancy tests.
• The rise in unplanned pregnancies is contributing to a higher demand for rapid testing solutions.

By Product Type

Midstream Pregnancy Tests:

Midstream pregnancy tests are gaining popularity due to their ease of use and accuracy. These tests typically come in a design that allows users to hold and dip the test in urine, providing clear and immediate results. The convenience of using midstream tests, combined with their reliable performance, has made them a preferred choice for many consumers. Additionally, advancements in the design and technology of these tests have enhanced their sensitivity, allowing for earlier detection of pregnancy hormones. Their user-friendly nature appeals particularly to those who may be anxious about the testing process, further driving their demand in the market.

Pregnancy Test Strips:

Pregnancy test strips are a cost-effective option for many consumers seeking to confirm pregnancy. These strips are typically inserted into a sample of urine, where a change in color indicates the presence of the hormone hCG. Their affordability and straightforward design make them an attractive option for users who may be testing repeatedly or those on a budget. Moreover, the availability of these strips in various pharmacies and online platforms ensures that they remain accessible to a wider audience. However, while they are economical, it is essential for consumers to follow the instructions closely to ensure accurate results.

Digital Pregnancy Tests:

Digital pregnancy tests represent a significant advancement in the market, offering users a clear and easy-to-read digital display that eliminates ambiguity in results. These tests utilize advanced technology to detect the presence of hCG hormones and provide results within minutes. The appeal of digital tests lies in their accuracy and the reassurance they provide to users who may be fearful of misreading traditional tests. The digitization of results also aligns with the growing consumer trend towards technological integration in health and wellness products, making digital tests a key segment of the pregnancy testing market.

Line Indicators:

Line indicators are a traditional method of pregnancy testing that remains in demand due to their simplicity and reliability. These tests generally involve two lines appearing on a test strip—one indicating the control line and the other indicating the presence of hCG. While more basic than some of their modern counterparts, line indicator tests have built a reputation for their effectiveness over the years. Many consumers appreciate the straightforwardness of this method and often prefer it for its familiarity, ensuring continued relevance in an evolving market.

Cassette Pregnancy Tests:

Cassette pregnancy tests are a popular option among healthcare professionals and home users alike. These tests come with a designated area for urine application and present results in a clear format, often resembling a test strip but housed within a protective casing. The design of cassette tests generally allows for greater accuracy and ease of use compared to traditional strips. They are frequently used in clinical settings due to their reliability, which instills confidence in both healthcare providers and patients. As this segment continues to innovate, it is expected to maintain a strong position within the broader pregnancy testing market.

By Application

Hospitals:

Hospitals represent a significant application segment for rapid pregnancy tests, primarily due to the need for quick and accurate results for patients. In emergency situations or routine check-ups, the ability to provide immediate pregnancy test results can significantly influence treatment decisions and care pathways. Hospitals utilize various types of tests, including digital and cassette formats, to ensure high accuracy and reliability in their results. As healthcare providers increasingly recognize the importance of timely diagnoses, the demand for rapid pregnancy tests in hospitals is anticipated to rise, contributing to market growth.

Clinics:

Clinics are another essential application area for rapid pregnancy tests, as they serve as primary care facilities for many individuals seeking reproductive health services. The ability to conduct pregnancy tests quickly allows clinics to facilitate timely counseling and management of pregnancy-related issues. Clinics often employ midstream tests and digital tests, which provide results within minutes, enabling healthcare professionals to make informed decisions regarding patient care promptly. The integration of pregnancy testing into routine clinic visits is expected to drive demand in this segment, aligning with the broader trend towards enhanced patient care and experience.

Household:

The household segment has experienced significant growth as more consumers opt for at-home pregnancy testing solutions. With the convenience of being able to test privately and without the need for a healthcare provider, household tests have become a go-to option for many. The availability of various product types, such as strips and digital tests, caters to diverse consumer preferences. The rising awareness of reproductive health and the increasing trend of self-diagnosis are propelling the demand for household pregnancy tests, making this segment one of the fastest-growing in the market.

Others:

Other application areas for rapid pregnancy testing include educational institutions and community health centers that may provide reproductive health services. These settings often require reliable testing solutions to support education and counseling efforts around pregnancy. The awareness campaigns and free testing initiatives in these environments can drive demand, particularly among younger demographics. While not as prominent as hospitals or clinics, the 'Others' segment continues to play a role in the overall market through targeted outreach and education regarding reproductive health.

By Distribution Channel

Pharmacies:

Pharmacies have long been a staple distribution channel for rapid pregnancy tests, offering a wide variety of product types to meet consumer needs. The accessibility of these tests in pharmacies allows individuals to purchase them discreetly, contributing to their popularity. Pharmacists also often provide guidance and support regarding the use of these tests, enhancing consumer confidence in their purchase decisions. The continual expansion of pharmacy chains and their focus on improving consumer experiences are expected to bolster the sales of pregnancy tests through this channel.

Online Retailing:

Online retailing has emerged as a rapidly growing channel for the distribution of pregnancy tests, catering to the increasing consumer preference for convenience and discretion. E-commerce platforms provide access to a wide range of products, often with the added benefit of competitive pricing and delivery options. This channel is particularly appealing to younger consumers who are more comfortable purchasing health-related products online. As online shopping continues to rise, companies that leverage digital marketing strategies and engage effectively with consumers are likely to see significant growth through this distribution channel.

Supermarkets:

Supermarkets are another important distribution channel for pregnancy tests, as they provide a wide array of health products including pregnancy testing kits. The convenience of shopping for multiple items in one location encourages consumers to purchase these tests during routine grocery shopping trips. This channel also benefits from high foot traffic, allowing manufacturers to reach a broader audience. As supermarkets increasingly highlight health and wellness sections within their stores, the visibility of pregnancy tests is expected to increase, supporting further market growth.

Drug Stores:

Drug stores serve as critical distribution points for rapid pregnancy tests, often providing a focused selection of health and wellness products. These stores cater to consumer needs by offering various testing kits in a discreet manner, contributing to their popularity among individuals seeking privacy. The staff in drug stores are typically knowledgeable about the products, which can enhance customer confidence and influence purchasing decisions. Additionally, the increasing number of drug stores in urban and suburban areas is likely to support higher sales of pregnancy tests.

Others:

Other distribution channels, which may include health fairs, community clinics, and mobile health units, also play a role in the availability of rapid pregnancy testing solutions. These channels often reach underserved areas, promoting awareness and accessibility to necessary healthcare products. Through outreach programs and educational efforts, these distributions can drive demand among populations who may not have easy access to traditional retail or pharmacy channels. As public health initiatives continue to expand, the influence of these alternative distribution channels on the pregnancy testing market is anticipated to grow.

By Technology

Lateral Flow Immunoassays:

Lateral flow immunoassays are among the most widely used technologies in rapid pregnancy tests, due to their simplicity and quick results. This technology employs a test strip that allows urine to flow through a membrane containing antibodies specific to hCG. When hCG is present, it binds to these antibodies, producing a visible line indicating pregnancy. The ease of use and rapid results have made lateral flow tests a popular choice for home testing, fueling their widespread adoption. The ongoing innovation in this technology continues to enhance reliability and sensitivity, making it a cornerstone of the pregnancy testing market.

Enzyme-linked Immunosorbent Assays (ELISA):

Enzyme-linked immunosorbent assays (ELISA) represent a highly sensitive technology used in professional settings for pregnancy testing. This method involves a more complex process that measures the presence of hCG by utilizing enzyme-linked antibodies, allowing for greater accuracy and earlier detection compared to traditional methods. While ELISA tests are primarily used in clinical environments, their precision makes them a valuable option for comprehensive pregnancy healthcare. As demand for high-accuracy testing continues, the ELISA technology segment is expected to grow alongside advancements in laboratory capabilities.

Radioimmunoassay:

Radioimmunoassay is one of the older technologies used in pregnancy testing but remains relevant in specialized clinical settings. This method utilizes radiolabeled antibodies to detect hCG levels in a sample, providing precise measurements. Although this technology offers high sensitivity and specificity, its complexity and need for specialized equipment limit its use to laboratory environments. As such, radioimmunoassay is less popular for at-home testing but continues to play a crucial role in research settings and advanced clinical diagnostics.

Others:

This segment includes emerging technologies and methodologies that are beginning to find applications in pregnancy testing. Innovations such as microfluidics and smartphone-integrated testing are poised to revolutionize the market by providing users with enhanced capabilities and connectivity. These newer technologies promise not only improved accuracy but also the ability to connect with digital health platforms for better tracking and management of reproductive health. As consumer preferences evolve, the incorporation of cutting-edge technologies into pregnancy testing is likely to create opportunities for market expansion.

By Linked Immunosorbent Assays

Direct ELISA:

Direct enzyme-linked immunosorbent assays (ELISA) are utilized in certain pregnancy tests to provide a straightforward and efficient measurement of hCG levels. This method relies on the binding of hCG directly to the enzyme-labeled antibody, resulting in a color change that indicates the presence of the hormone. The simplicity of the direct ELISA approach makes it suitable for both clinical and home testing scenarios, allowing for ease of use and interpretation. This segment is expected to retain relevance as more consumers seek effective and accessible testing solutions.

Indirect ELISA:

Indirect enzyme-linked immunosorbent assays (ELISA) are characterized by a two-step process in which hCG is first captured by a specific antibody before being detected by an enzyme-linked secondary antibody. This method enhances sensitivity and allows for the detection of lower concentrations of hCG, making it valuable in laboratory settings. While indirect ELISA is not commonly used in consumer pregnancy tests, it plays a critical role in research and advanced diagnostics, contributing to the broader understanding of pregnancy-related health.

Sandwich ELISA:

Sandwich ELISA is another approach utilized in advanced pregnancy testing strategies, where both capture and detection antibodies are used to measure hCG levels. This method allows for the formation of a “sandwich” complex with the target antigen (hCG), enhancing sensitivity and specificity. This technology is primarily employed in research laboratories and specialized clinical tests, providing precise measurement capabilities. As new research into reproductive health continues to emerge, the sandwich ELISA method may see increased application in pregnancy diagnostics.

By Region

North America:

North America holds a significant share of the rapid pregnancy testing market, driven by high consumer awareness, advanced healthcare infrastructure, and the availability of a diverse range of products. The market value in this region is estimated to be around USD 1.4 billion in 2023 and is expected to grow at a CAGR of approximately 7.5% through 2035. The increasing trend of at-home testing and the rising number of unplanned pregnancies are key factors contributing to market expansion. Moreover, the presence of prominent players and robust distribution channels further supports growth in this region, ensuring that consumers have access to the latest testing technologies.

Europe:

Europe is another major market for rapid pregnancy testing, with a valuation of approximately USD 1.2 billion in 2023. The region is anticipated to experience steady growth at a CAGR of 6.9% over the forecast period. Factors such as government initiatives promoting reproductive health, increasing awareness of testing options, and the adoption of home pregnancy testing kits are propelling market demand. Additionally, a growing focus on women's health and well-being is driving innovations in the development of more reliable and user-friendly testing products, further expanding market opportunities in Europe.

Opportunities

One of the primary opportunities in the rapid pregnancy testing market lies in the growing trend toward personalized healthcare. With advancements in technology, there is potential for the development of tests that not only confirm pregnancy but also provide additional health insights. This could include hormone level monitoring or reproductive health assessments, allowing consumers to have a more comprehensive understanding of their health status. Companies that invest in research and development to innovate and expand their product offerings in this direction are likely to capture a significant share of the market. Furthermore, collaborations with digital health platforms can also create synergies that enhance the overall consumer experience, making pregnancy testing more integrated into personal health management routines.

Another significant opportunity exists in emerging markets where access to reproductive health services may still be limited. As consumer awareness and demand for pregnancy testing continue to grow in these regions, companies can capitalize by expanding their distribution networks and tailoring products to local preferences and price points. Educational campaigns and partnerships with healthcare providers can further facilitate the adoption of rapid pregnancy tests in these areas. By focusing on affordability and accessibility, manufacturers can contribute to improving reproductive health awareness and outcomes in underserved populations, while simultaneously driving their business growth.

Threats

Despite the promising growth potential within the rapid pregnancy testing market, several threats could hinder market progress. One key concern is the increasing competition from low-cost alternatives and counterfeit products that can undermine consumer confidence and safety. As the market expands, the prevalence of subpar testing solutions might increase, leading to inaccurate results and potential health risks for consumers. This situation could erode trust in legitimate products and pose challenges for established manufacturers seeking to differentiate their offerings. To combat this threat, it is crucial for companies to maintain stringent quality control measures, invest in consumer education, and enhance brand reputation through transparent communication about product efficacy and safety.

Additionally, regulatory challenges pose a significant restrainer to the rapid pregnancy testing market. Different regions have unique regulatory requirements governing the approval and marketing of medical devices, including pregnancy tests. Navigating these complex frameworks can be daunting for manufacturers, particularly smaller companies, that may lack the resources to ensure compliance. Delays in obtaining necessary certifications could lead to missed market opportunities and hinder growth. To mitigate these risks, companies must stay informed about regulatory changes and proactively engage with regulatory authorities to ensure that their products meet the necessary standards for distribution.

Competitor Outlook

• Abbott Laboratories
• Roche Diagnostics
• Procter & Gamble Co.
• Quidel Corporation
• Church & Dwight Co., Inc.
• BD (Becton, Dickinson and Company)
• Hologic Inc.
• Clearblue (SPD Swiss Precision Diagnostics)
• First Response (Church & Dwight Co., Inc.)
• TestCard
• PREGMATE
• AccuQuik
• Easy@Home
• Fertility Focus
• MediSense

The competitive landscape of the rapid pregnancy testing market is characterized by a mix of established players and emerging companies striving to capture market share through innovation and product differentiation. Major companies such as Abbott Laboratories and Roche Diagnostics dominate the market due to their strong brand recognition, extensive product lines, and significant investments in research and development. These companies continuously seek to improve the accuracy, speed, and user-friendliness of their testing products, leveraging advanced technologies to stay ahead in a competitive environment. Additionally, they often engage in strategic partnerships and collaborations to enhance their market presence and expand their distribution networks, ensuring that their products reach a diverse consumer base.

Emerging players are also making significant strides in the market by focusing on niche segments and unique product offerings. Companies like TestCard and Easy@Home are utilizing innovative approaches to create pregnancy tests that cater specifically to consumer needs, such as incorporating smartphone technology or providing enhanced privacy features. These newcomers often adopt agile business models that allow them to quickly respond to consumer trends and preferences, positioning themselves as formidable competitors to established market leaders. As the market evolves, the competitive dynamics will continue to shift, with both established and emerging companies vying for prominence in the pregnancy testing landscape.

Among the key companies, Procter & Gamble Co. stands out with its Clearblue brand, known for its user-friendly digital tests and advanced technology. The company's commitment to research and development has allowed it to maintain a leading position in the consumer market. Similarly, Quidel Corporation offers a range of rapid testing solutions that emphasize accuracy and speed, appealing to both clinical and home users. These companies, along with others in the market, continuously innovate to meet consumer demands while ensuring compliance with regulatory standards. As the pregnancy testing market continues to grow, the competitive landscape will likely see increased investment and focus on product quality, consumer education, and effective marketing strategies.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 AccuQuik
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PREGMATE
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 TestCard
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Easy@Home
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 MediSense
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hologic Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fertility Focus
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Roche Diagnostics
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Quidel Corporation
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Abbott Laboratories
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Procter & Gamble Co.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Church & Dwight Co., Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 BD (Becton, Dickinson and Company)
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 First Response (Church & Dwight Co., Inc.)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Clearblue (SPD Swiss Precision Diagnostics)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Rapid Pregnancy Testing Market, By Technology
    • 6.1.1 Lateral Flow Immunoassays
    • 6.1.2 Enzyme-linked Immunosorbent Assays (ELISA)
    • 6.1.3 Radioimmunoassay
    • 6.1.4 Others
  • 6.2 Rapid Pregnancy Testing Market, By Application
    • 6.2.1 Hospitals
    • 6.2.2 Clinics
    • 6.2.3 Household
    • 6.2.4 Others
  • 6.3 Rapid Pregnancy Testing Market, By Product Type
    • 6.3.1 Midstream Pregnancy Tests
    • 6.3.2 Pregnancy Test Strips
    • 6.3.3 Digital Pregnancy Tests
    • 6.3.4 Line Indicators
    • 6.3.5 Cassette Pregnancy Tests
  • 6.4 Rapid Pregnancy Testing Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retailing
    • 6.4.3 Supermarkets
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Rapid Pregnancy Testing Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Rapid Pregnancy Testing market is categorized based on

By Product Type

• Midstream Pregnancy Tests
• Pregnancy Test Strips
• Digital Pregnancy Tests
• Line Indicators
• Cassette Pregnancy Tests

By Application

• Hospitals
• Clinics
• Household
• Others

By Distribution Channel

• Pharmacies
• Online Retailing
• Supermarkets
• Drug Stores
• Others

By Technology

• Lateral Flow Immunoassays
• Enzyme-linked Immunosorbent Assays (ELISA)
• Radioimmunoassay
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Abbott Laboratories
• Roche Diagnostics
• Procter & Gamble Co.
• Quidel Corporation
• Church & Dwight Co., Inc.
• BD (Becton, Dickinson and Company)
• Hologic Inc.
• Clearblue (SPD Swiss Precision Diagnostics)
• First Response (Church & Dwight Co., Inc.)
• TestCard
• PREGMATE
• AccuQuik
• Easy@Home
• Fertility Focus
• MediSense